Session Type
Meeting
Search Results
Abstract Number: 150
SHM Converge 2023
Background: A higher Helicobacter pylori (H. pylori) prevalence was associated with increased rates of post-operative complications including increased marginal ulceration and leak rates. Limited studies described prevalence of H. pylori in patients undergoing bariatric surgery and H. pylori associated upper and lower gastrointestinal bleeding (GIB). Primary Aim of our study was to evaluate the prevalence […]
Abstract Number: 151
SHM Converge 2023
Background: A priority of bedside electrocardiographic (ECG) monitoring is identification of ventricular tachycardia (VT), a lethal arrhythmia associated with morbidity and mortality. However, up to 87% of VT alarms could be false. In addition, little is known about the rate of mortality associated with VT. We assessed the rate of 30-day in-hospital mortality associated with […]
Abstract Number: 152
SHM Converge 2023
Background: Diabetes mellitus (DM) is a chronic disease where treatment is directed toward reducing and delaying its potentially severe short- and long-term complications. The estimated population (20-79 years old) with diabetes is 32.22 million in the United States, and 12.5% of people live with undiagnosed diabetes (Figure 1). Diabetes Mellitus is currently the most prevalent […]
Abstract Number: 153
SHM Converge 2023
Background: ST-segment elevation myocardial infarction (STEMI) is a cardiac emergency that requires timely reperfusion preferably with cardiac catheterization. The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2), has adversely impacted the delivery of healthcare to patients with STEMI. Several process changes were observed across the world during this period, including alternative cardiac […]
Abstract Number: 154
SHM Converge 2023
Background: Over the last few years, the USA has seen a sharp increase in the incidence and prevalence of substance use disorder (SUD) and related acute illnesses. The clinical course of many hospitalized patients is impacted by their diagnosis of SUD. At our institution, we put in place an inpatient addiction service where a physician […]
Abstract Number: 155
SHM Converge 2023
Background: Assessing and treating pain in older adults is challenging. Although having patients self-report pain on a numeric scale is the recommended approach, age-associated conditions such as dementia, delirium, and impaired vision or hearing can prevent patients from effectively communicating their symptoms. Older patients are also at risk of adverse effects from commonly used analgesics […]
Abstract Number: 156
SHM Converge 2023
Background: Although alcohol withdrawal (AW) is common in hospitalized patients, few studies describe contemporary alcohol withdrawal management in hospitalized settings or compare practices to recent guidelines published by the American Society of Addiction Medicine (ASAM). We sought to describe patient characteristics and determine factors associated with complicated withdrawal and treatment duration in hospitalized patients with […]
Abstract Number: 157
SHM Converge 2023
Background: While NT-proBNP has been known to predict mortality in heart failure patients and in hospitalized patients, its association with mortality in healthy adults without a history of cardiovascular disease is unknown. Further, it is unclear if a one-time measurement of NT-proBNP can predict distant mortality. Therefore, we examined the association between NT-proBNP with all-cause […]
Abstract Number: 158
SHM Converge 2023
Background: Patient experience is an important outcome for hospitals. These outcomes impact insurer payments, hospital ratings, and perceived quality of care (1). Like many hospitals, our patient experience is measured using Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys administered by Press Ganey (PG). Response rates to PG surveys are low, especially from […]
Abstract Number: 159
SHM Converge 2023
Background: Although novel oral anticoagulants (NOAC) have been proven as effective alternatives to warfarin in patients with atrial fibrillation, the effectiveness of NOACs in patients with artificial (bioprosthetic and mechanical) heart valves is not known. This systematic review and meta-analysis evaluates multiple clinical outcomes between warfarin and NOACs in patients with artificial heart valves. Methods: […]